The Barbara Ann Karmanos Cancer Institute is pleased to announce the launch of a Diversity and Inclusion Committee.
| DETROIT, Oct. 19, 2020 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute is pleased to announce the launch of a Diversity and Inclusion Committee. Led by this committee, Karmanos will integrate best practices in diversity, inclusion and cultural competence to deliver outstanding and equitable medical care to the patients we serve and provide a welcoming and supportive environment for staff members.
Justin Klamerus, M.D., MMM, president, Karmanos Cancer Hospital & Network will serve as executive sponsor of the local committee with Kay Carolin, chief nursing officer, as the chair. “Diversity at Karmanos has always been an organizational strength,” said Dr. Klamerus. “To enhance its power, we must continue to educate and embrace culture shifts, seek ways to improve, stay present and bridge gaps in care for our patient population. This cannot be done by the local committee alone. We will align with the McLaren Health Care corporate council and seek engagement from staff to empower the community we serve.” The Diversity and Inclusion Committee is comprised of members from many different areas of the organization from leadership and administration to clinical staff and researchers. They will hold their first meeting on October 19, 2020. In addition to core members, the committee will work with department leaders in identifying staff members to participate in initiatives to broaden the scope of voices and ideas. Karmanos’ Health Equity Book Club “Karmanos encourages everyone to learn more and support our community. Doing so makes us better caregivers, colleagues and individuals,” said Michael Simon, M.D., MPH, co-leader of the Breast Cancer Multidisciplinary Team and creator of Karmanos’ Health Equity Book Club. For more information and to register for the first virtual dialogue session on Thursday, October 22, 2020, from 4 – 5:30 p.m., visit www.karmanos.org/bookclub. “No time is soon enough for us to heighten our long-standing commitment to diversity and inclusion. Through open conversation, vulnerability and education, we can take steps that will allow us to better understand our patients, our colleagues and ourselves,” said Dr. Simon. A history of diversity and inclusion Additionally, Karmanos began working with the Surveillance, Epidemiology and End Results Program (SEER) in 1973, as one of the original nine registries. Karmanos contributes approximately 38% of the national cancer incidence and survival data for African Americans. The SEER registry is not only used for descriptive studies; it provides a population-based source of cases for case-control and case-case comparisons. Karmanos is also home to the Office of Cancer Health Equity and Community Engagement (OCHECE) whose mission is to eliminate cancer health disparities in Michigan by promoting community-engaged research and evidence-based strategies throughout Karmanos’ 46-county catchment area in Michigan. OCHECE programs include Michigan Cancer HealthLink, an academic-community partnership created to build community capacity to collaborate in cancer-related research and a Research and Advocacy Consortium (RAC). This growing network includes more than 30 faith-based, social service and public health organizations. The RAC works with OCHECE to support evidence-based interventions to improve cancer outcomes; inform diverse communities about clinical trials, cancer control, prevention, screening and treatment; aid in the dissemination and implementation of research discoveries; and advance health policy recommendations. “We are proud of the work we have already done to enhance equity in cancer care, and in the medical field overall. However, there is much more to be done. We are committed to fighting inequity, just as we are committed to fighting cancer,” said Dr. Klamerus. ABOUT THE BARBARA ANN KARMANOS CANCER INSTITUTE
SOURCE Karmanos Cancer Institute |
View original content to download multimedia:
